Vicinitas Therapeutics
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
442 Littlefield Ave, South San Francisco...Website
www.vicinitastx.comRevenue
<$5 MillionIndustry
About Vicinitas Therapeutics
Vicinitas Therapeutics Org Chart
Is Vicinitas Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Vicinitas Therapeutics recently announced quarterly report
Product Launch: Get notified when Vicinitas Therapeutics launches new products
Check out if Vicinitas Therapeutics is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Vicinitas Therapeutics
Funding: Get notified immidiatlly once Vicinitas Therapeutics has new funding data
Vicinitas Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Vicinitas Therapeutics had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Check if Vicinitas Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Vicinitas Therapeutics
Find more new buyers
Compare Similar Companies to Vicinitas Therapeutics
Compare insights from companies similar to Vicinitas Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Vicinitas Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Vicinitas Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Vicinitas Therapeutics.
Vicinitas Therapeutics financials insights
Gather financial insights about Vicinitas Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Series A
$65M
Vicinitas Therapeutics Tech Stack
A closer look at the technologies used by Vicinitas Therapeutics
Most Recent Scoops
Vicinitas Therapeutics News & Media
Vicinitas Therapeutics Appoints Christian Hofmann, Ph.D., as Chief Executive Officer
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Vicinitas Therapeutics, a biotechnology company advancing a proprietary targeted protein stabilization platform to develop novel therapeutics in cancer and genetic disorders, today announced that Christian Hofmann, Ph.D., has been appointed as the company’s Chief Executive Officer and member of the board of directors. “Since the launch of Vicinitas less than a year ago, we have made important progress in advancing our proprietary Deubiquitinase TargVicinitas Therapeutics Launches With $65 Million In Series A Financing
Financing led by a16z and Deerfield Management with participation from Droia Ventures, GV, The Mark Foundation for Cancer Research and... Read More The post Vicinitas Therapeutics Launches With $65 Million In Series A Financing appeared first on citybiz.
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Vicinitas Therapeutics
Based in San Francisco, CA, Vicinitas Therapeutics is a biotechnology company with a focus on cancer and genetic disorders.... Read More